Testing effectiveness (Phase 2)Study completedNCT01890746What this trial is testingA Safety and Efficacy Study of Eltrombopag in Subjects With AMLWho this might be right forAcute Leukaemia Novartis Pharmaceuticals 148
Large-scale testing (Phase 3)Study completedNCT03362177What this trial is testingStudy of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal CancerWho this might be right forChemotherapy-induced Thrombocytopenia Amgen 165
Early research (Phase 1)Ended earlyNCT01491594What this trial is testingEltrombopag for the Prevention of Chemotherapy Induced ThrombocytopeniaWho this might be right forSarcoma, Soft TissueOsteosarcomaNeoplasms, Connective and Soft Tissue Duke University 1
Not applicableUnknownNCT03049774What this trial is testingThe Recombinant Human Interleukin-11 (I) (Baijieyi) for Prevention and Treatment of Chemotherapy-induced Thrombocytopenia in Patients With Malignant TumorWho this might be right forChemotherapy-induced Thrombocytopenia Angde Biotech Pharmaceutical Co., Ltd. 2,000
Not applicableEnrolling By InvitationNCT06769685What this trial is testingTPO Combined With TPORA for Solid Tumors Effectiveness of cTit Above Degree IIWho this might be right forCTIT-Chemotherapy Induced Thrombocytopenia Jinhua Central Hospital 100
Not applicableStudy completedNCT03567798What this trial is testingThrombocytopenia Induced by ChemotherapyWho this might be right forThrombocytopenia Socrates School Of Health 60
Early research (Phase 1)Active Not RecruitingNCT05426369What this trial is testingA Clinical Trial Evaluating SCB-219M in in Chemotherapy-induced Thrombocytopenia (CIT)Who this might be right forChemotherapy-induced Thrombocytopenia (CIT) Sichuan Clover Biopharmaceuticals, Inc. 36
Testing effectiveness (Phase 2)Study completedNCT05772546What this trial is testingAvatrombopag vs. Placebo for CIT in GI MalignanciesWho this might be right forGastrointestinal CancerGastrointestinal NeoplasmsChemotherapy-Induced Thrombocytopenia Hanny Al-Samkari, MD 49
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07243418What this trial is testingHetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 StudyWho this might be right forCTIT-Chemotherapy Induced ThrombocytopeniaBreast Cancer Fujian Cancer Hospital 72
Testing effectiveness (Phase 2)Study completedNCT00102726What this trial is testingSB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving ChemotherapyWho this might be right forThrombocytopaenia GlaxoSmithKline 183
Testing effectiveness (Phase 2)Study completedNCT04673266What this trial is testingUsing Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With LymphomaWho this might be right forLymphoma PatientsThrombocytopenia Memorial Sloan Kettering Cancer Center 11
Testing effectiveness (Phase 2)Looking for participantsNCT07043894What this trial is testingRomiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer PatientsWho this might be right forSolid TumorsHematological TumorChildren+2 more Cancer Institute and Hospital, Chinese Academy of Medical Sciences 50
Testing effectiveness (Phase 2)UnknownNCT05252091What this trial is testingAn Exploratory Study of Herombopag for Thrombocytopenia Induced by Chemotherapy Combined With Immunotherapy in NSCLCWho this might be right forNon-small Cell Lung Cancer Henan Cancer Hospital 30
Testing effectiveness (Phase 2)UnknownNCT05218226What this trial is testingAvatrombopag for Chemotherapy-induced ThrombocytopeniaWho this might be right forChemotherapy-induced ThrombocytopeniaAvatrombopag Institute of Hematology & Blood Diseases Hospital, China 50
Testing effectiveness (Phase 2)Study completedNCT00413283What this trial is testingDose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)Who this might be right forLung CancerChemotherapy-Induced ThrombocytopeniaNon-Small Cell Lung Cancer+5 more Amgen 63
Large-scale testing (Phase 3)Active Not RecruitingNCT03937154What this trial is testingStudy of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast CancerWho this might be right forChemotherapy-induced Thrombocytopenia Amgen 145
Large-scale testing (Phase 3)Study completedNCT05851027What this trial is testingEvaluating the Efficacy and Safety of QL0911 in Chemotherapy- Induced ThrombocytopeniaWho this might be right forChemotherapy-induced Thrombocytopenia Qilu Pharmaceutical Co., Ltd. 50
Large-scale testing (Phase 3)UnknownNCT02093325What this trial is testingAssess the Efficacy and Safety of Eltrombopag as a Rescue of Isolated Chemotherapy-induced ThrombocytopeniaWho this might be right forSolid Tumor Chang Gung Memorial Hospital 83
Testing effectiveness (Phase 2)Ended earlyNCT00926354What this trial is testingApplication of AS101 for the Treatment of Thrombocytopenia in Solid Tumor PatientsWho this might be right forChemotherapy Induced Thrombocytopenia BioMAS Ltd 40
Testing effectiveness (Phase 2)UnknownNCT06099925What this trial is testingThe Efficacy and Safety of Hetrombopag as Secondary Prevention to Chemotherapy-induced Thrombocytopenia in Patients With Gynecologic MalignanciesWho this might be right forChemotherapy-induced Thrombocytopenia Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 48